NEW IMMUNOTHERAPY TARGET AGAINST SEVERAL BLOOD TUMORS, PARTICULARLY CHRONIC LYMPHOIDS LEUKEMIA (CLL)
MA50590AUndetermined Publication Date: 2020-09-16IMMATICS BIOTECHNOLOGIES GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- MA50590
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-06-20
- Filing Date
- 2015-06-17
- Publication Date
- 2020-09-16
Need to check novelty before this filing date? Find Prior Art
No text content released.